Literature DB >> 16168518

Transgenic overexpression of interleukin-8 in mouse liver protects against galactosamine/endotoxin toxicity.

Jennifer C Hanson1, Michele K Bostick, Carson B Campe, Pratima Kodali, Gene Lee, Jim Yan, Jacquelyn J Maher.   

Abstract

BACKGROUND/AIMS: CXC chemokines function as survival factors for several types of cells. In this study, we investigated whether CXC chemokines promote survival of liver cells following an apoptotic stimulus in vivo.
METHODS: Apoptosis was induced in mouse liver by treatment with galactosamine and endotoxin (Gal/ET). The influence of CXC chemokines was investigated by comparing Gal/ET responses in wild-type (WT) mice to those in mice with a transgene encoding the CXC chemokine interleukin-8 (IL-8 TG).
RESULTS: IL-8 TG mice displayed less apoptosis and better survival after Gal/ET treatment than did WT mice (60% fewer TUNEL-positive cells at 6 h; 36% better survival at 24 h). Gal/ET toxicity was also preventable in WT mice by pre-treatment with IL-8. Notably, IL-8 was not protective against hepatic apoptosis due to anti-Fas or concanavalin A. In Gal/ET-treated mice, IL-8 promoted liver cell survival by interfering with the mitochondrial pathway of apoptosis. Survival was not attributable to activation of NF-kappaB or up-regulation of anti-apoptotic proteins, but coincided instead with activation of Akt and phosphorylation of the pro-apoptotic protein Bad.
CONCLUSIONS: IL-8 protects liver cells from Gal/ET-mediated apoptosis by signaling through phosphatidylinositol-3 kinase (PI-3K). This is in keeping with the reported mechanism of chemokine-related survival in other tissues.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16168518     DOI: 10.1016/j.jhep.2005.06.022

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  7 in total

Review 1.  Adiponectin, a key adipokine in obesity related liver diseases.

Authors:  Christa Buechler; Josef Wanninger; Markus Neumeier
Journal:  World J Gastroenterol       Date:  2011-06-21       Impact factor: 5.742

Review 2.  IL-33/ST2 axis in inflammation and immunopathology.

Authors:  Marija Milovanovic; Vladislav Volarevic; Gordana Radosavljevic; Ivan Jovanovic; Nada Pejnovic; Nebojsa Arsenijevic; Miodrag L Lukic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

3.  Functional Deficits in Mice Expressing Human Interleukin 8.

Authors:  Julie Michelle Brent; Zuozhen Tian; Lutian Yao; Jian Huang; Dessislava Z Markova; Frances S Shofer; Angela K Brice; Ling Qin; Carla R Scanzello; Flavia Vitale; Di Chen; Yejia Zhang
Journal:  Comp Med       Date:  2020-04-20       Impact factor: 0.982

4.  Circulating interleukin-8 levels explain breast cancer osteolysis in mice and humans.

Authors:  Archana Kamalakar; Manali S Bendre; Charity L Washam; Tristan W Fowler; Adam Carver; Joshua D Dilley; John W Bracey; Nisreen S Akel; Aaron G Margulies; Robert A Skinner; Frances L Swain; William R Hogue; Corey O Montgomery; Parshawn Lahiji; Jacqueline J Maher; Kim E Leitzel; Suhail M Ali; Alan Lipton; Richard W Nicholas; Dana Gaddy; Larry J Suva
Journal:  Bone       Date:  2014-01-28       Impact factor: 4.398

Review 5.  The roles of Galectin-3 in autoimmunity and tumor progression.

Authors:  Gordana Radosavljevic; Vladislav Volarevic; Ivan Jovanovic; Marija Milovanovic; Nada Pejnovic; Nebojsa Arsenijevic; Daniel K Hsu; Miodrag L Lukic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

6.  Expression of Human Interleukin 8 in Mice Alters Their Natural Behaviors.

Authors:  Zuozhen Tian; Frances S Shofer; Alec Z Sandroni; Lan Zhao; Carla R Scanzello; Yejia Zhang
Journal:  J Inflamm Res       Date:  2022-04-13

7.  Hepatitis B Virus Activates Signal Transducer and Activator of Transcription 3 Supporting Hepatocyte Survival and Virus Replication.

Authors:  Marianna Hösel; Maria Quasdorff; Marc Ringelhan; Hamid Kashkar; Svenja Debey-Pascher; Martin F Sprinzl; Jan-Hendrik Bockmann; Silke Arzberger; Dennis Webb; Gesa von Olshausen; Achim Weber; Joachim L Schultze; Hildegard Büning; Mathias Heikenwalder; Ulrike Protzer
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2017-07-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.